Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses

• Auteurs principaux: Weiping Cao (Auteur), Margarita Mishina (Auteur), Samuel Amoah (Auteur), Wadzanai P. Mboko (Auteur), Caitlin Bohannon (Auteur), James McCoy (Auteur), Suresh K. Mittal (Auteur), Shivaprakash Gangappa (Auteur), Suryaprakash Sambhara (Auteur)
• Format: Livre
• Publié: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Avian influenza virus infection is a serious public health threat and preventive vaccination is the most cost-effective public health intervention strategy. Unfortunately, currently available unadjuvanted avian influenza vaccines are poorly immunogenic and alternative vaccine formulations and delive...